Medicare Enrolled

Dr. Justin Lindquist, M.D.

Neurology · Orlando, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3849 OAKWATER CIR, Orlando, FL 32806
4072401762
In practice since 2006 (19 years)
NPI: 1457411944 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lindquist from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lindquist? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lindquist

Dr. Justin Lindquist is a neurology in Orlando, FL, with 19 years in practice. Based on federal Medicare data, Dr. Lindquist performed 389 Medicare services across 344 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lindquist received a total of $12,794 from 65 pharmaceutical and/or device companies across 782 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lindquist is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 389 Medicare services$ $12,794 industry payments

Medicare Practice Summary

Medicare Utilization ↗
389
Medicare services
Bottom 42% in FL for neurology
344
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)96$95$217
New patient office visit (45-59 min)81$127$288
Needle measurement of electrical activity in arm or leg muscles, complete study76$75$174
New patient office visit, complex (60-74 min)41$162$445
Office visit, established patient (20-29 min)36$66$162
New patient office visit (30-44 min)20$88$170
Nerve conduction, 5-6 studies15$92$290
Nerve conduction, 9-10 studies13$163$456
Nerve conduction, 7-8 studies11$135$298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,794
Total received (2018-2024)
Avg $1,828/year across 7 years
Top 24% in FL for neurology
65
Companies
782
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,736 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$58 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$866
2023
$1,465
2022
$2,008
2021
$2,278
2020
$1,898
2019
$2,331
2018
$1,947

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$1,349
Novartis Pharmaceuticals Corporation
$1,056
Amgen Inc.
$988
EMD Serono, Inc.
$868
GENZYME CORPORATION
$866
Lilly USA, LLC
$827
ABBVIE INC.
$754
Alexion Pharmaceuticals, Inc.
$754
Sunovion Pharmaceuticals Inc.
$520
Biohaven Pharmaceuticals, Inc.
$484
AbbVie Inc.
$327
Allergan, Inc.
$301
Lundbeck LLC
$275
Biogen, Inc.
$267
Biohaven Pharmaceutical Holding Company Ltd.
$240
PFIZER INC.
$210
ARGENX US, INC.
$170
Bausch Health US, LLC
$154
Avanir Pharmaceuticals, Inc.
$154
Supernus Pharmaceuticals, Inc.
$131
Mallinckrodt Hospital Products Inc.
$128
Alnylam Pharmaceuticals Inc.
$127
Celgene Corporation
$113
Genentech USA, Inc.
$110
Mallinckrodt Enterprises LLC
$109
TG THERAPEUTICS, INC.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$90
Zyla Life Sciences, Inc.
$82
Horizon Therapeutics plc
$69
Mallinckrodt LLC
$66
UPSHER-SMITH LABORATORIES LLC
$59
Acorda Therapeutics, Inc
$58
CALLIDITAS THERAPEUTICS US INC.
$57
Currax Pharmaceuticals LLC
$57
Assertio Therapeutics, Inc.
$56
CATALYST PHARMACEUTICALS, INC.
$48
US WorldMeds, LLC
$44
Merck Sharp & Dohme LLC
$43
GE HEALTHCARE
$43
BANNER LIFE SCIENCES, LLC
$39
Jazz Pharmaceuticals Inc.
$39
Allergan Inc.
$37
IMPEL PHARMACEUTICALS INC.
$37
Grifols USA, LLC
$36
Harmony Biosciences LLC
$35
Neurocrine Biosciences, Inc.
$34
Upsher-Smith Laboratories LLC
$29
CSL Behring
$29
Amneal Pharmaceuticals LLC
$29
Eisai Inc.
$27
UCB, Inc.
$27
Pacira Pharmaceuticals Incorporated
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
AbbVie, Inc.
$21
Calliditas Therapeutics US Inc.
$21
Azurity Pharmaceuticals, Inc.
$19
EISAI INC.
$19
Endo Pharmaceuticals Inc.
$16
Adamas Pharmaceuticals, Inc.
$15
Avion Pharmaceuticals
$15
MDD US Operations, LLC
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Zyla Life Sciences
$12
Dynasplint Systems Inc.
$12
Top 3 companies account for 26.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · CAMBIA · CONTRAVE · COPAXONE · Cambia · DIFICID · DUOPA · Dhivy · Duopa · Dynasplint · EMGALITY · Edarbi · Exparel · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NASCOBAL · NUEDEXTA · NURTEC ODT · OCREVUS · ONGENTYS · ONPATTRO · ONZETRA Xsail · Ocrevus · PAXLOVID · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · TARPEYO · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,289 per 100 Medicare services performed
Looking for a neurology in Orlando?
Compare neurologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
92
Per 100K population
6.4
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lindquist is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lindquist experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lindquist performed 96 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lindquist receive payments from pharmaceutical companies?
Yes. Dr. Lindquist received a total of $12,794 from 65 companies across 782 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lindquist's costs compare to other neurologys in Orlando?
Dr. Lindquist's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lindquist) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →